Company news
Alebund Pharmaceuticals (Jiangsu) Limited news in 2026
Alebund Pharmaceuticals (Jiangsu) Limited's news releases, calls and decks from 2026, newest first.
Next Day Disclosure Return
November 13, 2026
Next Day Disclosure Return
November 6, 2026
Next Day Disclosure Return
November 5, 2026
Next Day Disclosure Return
November 4, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 4, 2026
Next Day Disclosure Return
November 3, 2026
Next Day Disclosure Return
November 2, 2026
Voluntary announcement - on-market share repurchase
October 20, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
October 6, 2026
2026 Interim report
September 17, 2026
Alebund's AP301 NDA Accepted for Review by China's NMPA
August 7, 2026
Announcement of final offer price and allotment results
June 26, 2026
List of directors and their roles and functions
June 25, 2026
Documents on Display
June 17, 2026
PHIP (1st submission)
June 14, 2026